First Manhattan
COLL icon

First Manhattan’s Collegium Pharmaceutical COLL Stock Holding History

First Manhattan’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-382
Closed -$9K – 1395
2018
Q2 		$9K Buy
382
+191
+100% +$4.7K ﹤0.01% 1196
2018
Q1 		$4K Sell
191
-466,009
-100% -$11.1M ﹤0.01% 1273
2017
Q4 		$8.61M Buy
+466,200
New +$6.68M 0.05% 208

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan's COLL Position: Q3 2018 in Review

First Manhattan sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 382 shares — an estimated $9K sold.

First Manhattan first reported a position in COLL in Q4 2017 and held it in 3 quarters. The position peaked at $8.61M in Q4 2017. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

  • First Manhattan reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
  • First Manhattan sold 382 Collegium Pharmaceutical shares in Q3 2018, an estimated $9K.
  • First Manhattan first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 3 quarters.
  • First Manhattan's Collegium Pharmaceutical position peaked at $8.61M in Q4 2017.
  • 124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on First Manhattan's 13F filing for Q3 2018, filed 15 Oct 2018.